Conclusions
atherosclerosis
ATHEROSCLEROSIS, OXIDATIVE STRESS, ASYMPTOMATIC HYPERURICEMIA, CAROTID ATHEROSCLEROSIS
Our findings may indicate a possibility that febuxostat can lower the MDA‐LDL/LDL‐C ratio, a potential marker of atherosclerosis and oxidative stress, in asymptomatic hyperuricemic patients with carotid atherosclerosis. Further studies are required to validate our findings and elucidate the clinical antioxidant effect of febuxostat.IMT, intima‐media thickness; LDL‐C, low‐density lipoprotein cholesterol; MDA‐LDL, malondialdehyde‐modified low‐density lipoprotein; UA, uric acid.
